Polyol Project revs up.
PKN beats Mol in downstream, though.
For the commercialisation of novel drug in Europe, Latin America and other markets.
Aims to boost market share to 7-8%.
Agreement with trade unions reached.
Guessing game has been on for a while now.
Erik Bogsch will remain Chairman of the Board, though.
Shoots up 150 places.
For incentive programme.
Half-yearly and annual reports will remain.
Lending growth envisaged.
Key dates of 8 for 1 share split revealed.
Lending keeps expanding.
94 million forints worth of OTP shares.
There's a first time for everything.
Other execs sold OTP shares too.
We haven't seen that for a long time.
If it were not for another nasty one-off item...
The Polish acquisition is expected to save EUR 5 mn in synergies next year.